by admin_63069 | Sep 30, 2022 | Related Topics
Learn more about the uses of PSMA imaging.
by admin_63069 | Sep 26, 2022 | Related Topics
Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.
by admin_63069 | Sep 22, 2022 | Related Topics
Trial shows this approach improves metastasis-free survival in prostate cancer.
by admin_63069 | Sep 20, 2022 | Related Topics
A new artificial intelligence-based approach by Avenda Health is poised to potentially revolutionize the treatment landscape in the field.
by admin_63069 | Sep 16, 2022 | Related Topics
Phillip H. Kuo, MD, PhD, spoke about the future of theragnostic imaging in patients with metastatic castration-resistant prostate cancer.
by admin_63069 | Sep 12, 2022 | Related Topics
Costs and time might be reduced by eliminating other exams and just using PSMA-PET.
